Abstract:Xiaoyi Tang, 1, 2, &ast Yijia Liu, 1, 2, &ast Mengxin Zhao, 3, &ast Lei He, 3 Jiahao Guo, 3 Tian Wang, 3 Wei Li, 3 Jiaqi Zhao 1 1 Department of Ultrasound, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, 200434, People's Republic of China; 2 Department of Ultrasound, the Second Affiliated Hospital of Naval Medical University (Shanghai Changzheng Hospital), Shanghai, 200003, People's Republic of China; 3 Department of Nanomedicine, Naval Medical University, Shanghai & School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200433, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wei Li; Jiaqi Zhao, Email ; Purpose: This study aims to broaden the application of nano-contrast agents (NCAs) within the realm of the musculoskeletal system. It aims to introduce novel methods, strategies, and insights for the clinical management of ischemic muscle disorders, encompassing diagnosis, monitoring, evaluation, and therapeutic intervention. Methods: We developed a composite encapsulation technique employing O-carboxymethyl chitosan (OCMC) and liposome to encapsulate NCA-containing gold nanorods (GNRs) and perfluoropentane (PFP). This nanoscale contrast agent was thoroughly characterized for its basic physicochemical properties and performance. Its capabilities for in vivo and in vitro ultrasound imaging and photothermal imaging were authenticated, alongside a comprehensive biocompatibility assessment to ascertain its effects on microcirculatory perfusion in skeletal muscle using a murine model of hindlimb ischemia, and its potential to augment blood flow and facilitate recovery. Results: The engineered GNR@OCMC-liposome/PFP nanostructure exhibited an average size of 203.18± 1.49 nm, characterized by size uniformity, regular morphology, and a good biocompatibility profile. In vitro assessments revealed NCA's potent photothermal response and its transformation into microbubbles (MBs) under near-infrared (NIR) irradiation, thereby enhancing ultrasonographic visibility. Animal studies demonstrated the nanostructure's efficacy in photothermal imaging at ischemic loci in mouse hindlimbs, where NIR irradiation induced rapid temperature increases and significantly increased blood circulation. Conclusion: The dual-modal ultrasound/photothermal NCA, encapsulating GNR and PFP within a composite shell-core architecture, was synthesized successfully. It demonstrated exceptional stability, biocompatibility, and phase transition efficiency. Importantly, it facilitates the encapsulation of PFP, enabling both enhanced ultrasound imaging and photothermal imaging following NIR light exposure. This advancement provides a critical step towards the integrated diagnosis and treatment of ischemic muscle diseases, signifying a pivotal development in nanomedicine for musculoskeletal therapeutics. Keywords: ultrasonography, nanoscale contrast agent, nanotechnology, musculoskeletal ultrasound, photothermal imaging, microcirculatory perfusion Skeletal muscle is the most susceptible tissue to ischemia, with microcirculatory dysfunction recognized as a crucial early event in ischemic muscle injury. 1 Microcirculation injury, particularly in skeletal muscle of the lower limbs, is closely associated with the progression of peripheral vascular disease and diabetic lower limb lesions. 2 When ischemic injury occurs in skeletal muscle, early clinical manifestations may not be obvious, there is a notable absence of validated methods for effective evaluation of microcirculation at the muscle extremities. Traditional macrovascular perfusion assessments, such as color Doppler flow imaging (CDFI), do not adequately capture microvascular perfusion in skeletal muscle. Consequently, non-invasive and real-time imaging techniques that can accurately evaluate skeletal muscle microcirculatory perfusion are essential for the early detection, diagnosis, and treatment efficacy assessment of limb and muscle ischemic injuries. Studies have demonstrated the potential of ultrasonography as an effective tool for monitoring muscle involvement, regenerative processes, and the efficacy of anti-inflammatory treatments. 3,4 Conventional microbubble (MB) ultrasound contrast agents (UCAs), with their micron-scale size, predominantly facilitate blood pool imaging, given their average diameter spanning approximately 2–4 μm. However, recent advancements in nanotechnology have led to the emergence of various nano-contrast agents (NCAs). These NCAs, through thei -Abstract Truncated-

Iodinated gadolinium-gold nanomaterial as a multimodal contrast agent for cartilage tissue imaging

Gadolinium-hyaluronic acid nanoparticles as an efficient and safe magnetic resonance imaging contrast agent for articular cartilage injury detection

Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents.

Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics

Contrast enhanced computed tomography for real-time quantification of glycosaminoglycans in cartilage tissue engineered constructs

Poly(Acrylic Acid) Bridged Gadolinium Metal-Organic Framework-Gold Nanoparticle Composites As Contrast Agents for Computed Tomography and Magnetic Resonance Bimodal Imaging

Simultaneous Quantitation of Cationic and Non-ionic Contrast Agents in Articular Cartilage Using Synchrotron MicroCT Imaging

Computed Tomography of Cartilage: an Exploration of Novel Cationic Bismuth Contrast Agent.

Ultra-small superparamagnetic iron oxide nanoparticles for intra-articular targeting of cartilage in early osteoarthritis

Facile Synthesis of Gd-Functionalized Gold Nanoclusters As Potential MRI/CT Contrast Agents

Gold Nanorod-Loaded Nano-Contrast Agent with Composite Shell-Core Structure for Ultrasonic/Photothermal Imaging-Guided Therapy in Ischemic Muscle Disorders

Multimodal Bioimaging Based on Gold Nanorod and Carbon Dot Nanohybrids As a Novel Tool for Atherosclerosis Detection

Spectral CT imaging of human osteoarthritic cartilage via quantitative assessment of glycosaminoglycan content using multiple contrast agents

Gold Nanoclusters for NIR‐II Fluorescence Imaging of Bones

Targeted Delivery of Hesperetin to Cartilage Attenuates Osteoarthritis by Bimodal Imaging with Gd2(CO3)3@PDA Nanoparticles Via TLR-2/NF-κB/Akt Signaling.

Effect of Computed Tomography Scanning Parameters on Gold Nanoparticle and Iodine Contrast

Carboxymethyl chitosan-assisted MnOx nanoparticles: Synthesis, characterization, detection and cartilage repair in early osteoarthritis

Ligand Engineering of Gold Nanoclusters for NIR-II Imaging

Quantitative imaging of excised osteoarthritic cartilage using spectral CT

Coupling Gold Nanospheres into Nanochain Constructs for High-Contrast, Longitudinal Photoacoustic Imaging

The Value of CTA Based on Gold Nanorod Contrast Agent in Coronary Artery Diagnosis and Plaque Property Analysis